Kalaris to Present at Clinical Trials at the Summit 2026
Go back to Kalaris to Present at Clinical Trials at the Summit 2026| (NASDAQ: KLRS) | Delayed: 2.19 +0.06 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.13 | 52 Week High | $ | |||
| Open | $2.20 | 52 Week Low | $ | |||
| Day High | $2.23 | P/E | N/A | |||
| Day Low | $2.10 | EPS | $ | |||
| Volume | 56,980 | |||||



